Electroporation for therapeutic DNA vaccination in patients (Q38298562)

1 September 2017

1 reference

title

Electroporation for therapeutic DNA vaccination in patients (English)

1 reference

1 September 2017

1 reference

2

1 reference

1 September 2017

Matti Sällberg

1

1 reference

1 September 2017

Gustaf Ahlén

series ordinal

3

1 reference

1 September 2017

Margaret Sällberg-Chen

series ordinal

4

1 reference

1 September 2017

23 December 2014

1 reference

Medical Microbiology and Immunology

1 September 2017

1 reference

1 September 2017

204

1 reference

1 September 2017

131-135

1 reference

1 September 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s00430-014-0384-8

1 September 2017

0 references

cites work

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0384-8

Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0384-8

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0384-8

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0384-8

Permeability changes induced by electric impulses in vesicular membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0384-8

Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0384-8

Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0384-8

Gene transfer into muscle by electroporation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0384-8

Electropermeabilization of skeletal muscle enhances gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0384-8

In vivo electroporation enhances the immunogenicity of hepatitis C virus nonstructural 3/4A DNA by increased local DNA uptake, protein expression, inflammation, and infiltration of CD3+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0384-8

Enhancement of immune responses to an HBV DNA vaccine by electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0384-8

The danger model: a renewed sense of self

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0384-8

The control of adaptive immune responses by the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0384-8

Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0384-8

Therapeutic DNA vaccination using in vivo electroporation followed by standard of care therapy in patients with genotype 1 chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0384-8

DNA electroporation of multi-agent vaccines conferring protection against select agent challenge: TriGrid delivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0384-8

Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0384-8

Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0384-8

In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0384-8

High-velocity microprojectiles for delivering nucleic acids into living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0384-8

Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-014-0384-8

Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial

21 January 2018

1 reference

12 December 2020

Treatment of cutaneous nodules using electrochemotherapy

1 reference

12 December 2020

High-velocity microprojectiles for delivering nucleic acids into living cells. 1987

1 reference

12 December 2020

Gene transfer into mouse lyoma cells by electroporation in high electric fields

1 reference

12 December 2020

10.1007/S00430-014-0384-8

Identifiers

DOI

1 reference

Dimensions Publication ID

1 September 2017

1012336688

0 references

Fatcat ID

release_3hoeqj276fdi3oarisljgz4n5a

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3hoeqj276fdi3oarisljgz4n5a

24 November 2022

mapped directly with Wikidata item

1 reference